Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Travoprost APS versus Xalatan: patient-reported outcomes and ocular surface health
2009-010606-10Phase 3Completed
- Sponsor
- Alcon Inc.
- Start
- Apr 2009
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of travoprost in open-angle glaucoma (OAG) and ocular hypertension (2 arms), sponsored by Alcon Inc. Started Apr 2009; status: completed.
02
Drugs
travoprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on 2009-010606-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010606-10.